pentofuranose-4-yl)-hept-5-enoate 15 (1 g, 2.87 mmol) and adenine 17 (0.39 g, 2.87 mmol) in presence of DBU (0.44 ml, 2.87 mmol) refluxed in methanol (30 ml) as describe above give the mixture diastereomeric compounds. 5, 155.7, 152.8, 150.0, 142.4, 136.8, 128.8, 128.4, 128.1, 120.2, 112.5, 105.5, 82.0, 81.5, 78.6, 72.3, 52.5, 51.1, 35.2, 27.1, 26.6 170.5, 155.6, 152.4, 150.1, 142.3, 136.7, 128.9, 128.6, 128.4, 120.6, 112.6, 105.1, 82.1, 80.8, 78.5, 71.9, 53.7, 52.1, 34.1, 27.1, 26.7; HRMS: Calcd. Accurate mass for (C 23 4, 155.6, 152.8, 150.0, 149.4, 142.6, 140.5, 134.6, 126.6, 122.0, 120.3, 114.6, 113.0, 105.5, 82.0, 80.5, 77.9, 61.1, 52.6, 35.5, 26.9, 26.6, 14 4, 155.7, 152.4, 150.0, 149.6, 142.6, 140.6, 134.6, 126.6, 122.3, 120.6, 114.9, 113.1, 105.0, 82.4, 81.3, 78.2, 61.3, 54.0, 34.7, 27.0, 26.7, 14 8, 154.6, 152.8, 141.5, 138.5, 136.6, 128.7, 128.6, 128.2, 127.8, 127.5, 120.1, 112.3, 105.3, 81.9, 81.3, 78.5, 72.1, 60.7, 52.3, 35.4, 26.9, 26.4, 14. 8, 154.6, 152.4, 141.4, 138.5, 136.5, 128.7, 128.4, 128.2, 127.8, 127.4, 120.4, 112.4, 104.9, 81.9, 80.6, 78.5, 71.7, 65.8, 60.9, 53.5, 34.3, 26.9, 26.5, 15.3, 14 8, 154.9, 152.8, 141.2, 136.6, 128.6, 128.2, 127.8, 112.2, 105.3, 81.9, 81.3, 78.5, 72.1, 60.7, 52.2, 35.4, 31.9, 30.9, 29.6, 29.6, 29.6, 29.4, 29.3, 27.0, 26.9, 26.4, 22.7, 14.1, 14. 8, 154.9, 141.1, 136.5, 128.6, 128.4, 128.2, 112.4, 104.8, 81.9, 80.6, 78.5, 71.7, 60.9, 53.5, 34.3, 31.9, 30.9, 29.6, 29.6, 29.6, 29.4, 29.3, 27.0, 26.9, 26.5, 22.7, 14 
Major Isomer (20a)
:H
Ethyl-[3-O-(2-nitrophenyl)-5,6-dideoxy-5-(6-amino-9H-purin-9-yl)-1,2-Oisopropylidene]-β-L-ido and α-D-glucoheptofuranuronates (21

General procedure for the synthesis of compounds 24-29
To a magnetically stirred slurry of LiAlH 4 (0.012 g, 0.30 mmol) in anhydrous THF 5, 152.9, 150.1, 140.3, 136.4, 128.5, 128.2, 128.0, 119.3, 112.1, 105.3, 81.7, 81.4, 80.1, 72.0, 58.1, 51.6, 34.7, 26.9, 26 5, 152.7, 149.9, 149.3, 141.7, 140.2, 134.4, 126.4, 121.7, 114.3, 112.6, 105.3, 81.7, 80.7, 78.9, 58.4, 52.8, 33.5, 26.7, 26.4 
5-(6-benzylamino-9H-purin-9-yl)-5,6-dideoxy-6-hydroxymethyl-1,2-Oisopropylidene-3-O-benzyl-β-L-idofuranose (26).
It was obtain by the reduction of 152.4, 149.7, 141.8, 140.2, 134.4, 126.4, 125.5, 121.9, 114.5, 112.7, 104.8, 82.1, 81.2, 78.8, 57.9, 53.8, 33.0, 30.3, 29.7, 26.8, 26.5 7, 152.7, 140.0, 138.5, 136.6, 128.7, 128.5, 128.2, 128.2, 128.0, 127.7, 127.4, 119.5, 112.1, 104.8, 81.8, 81.5, 79.8, 72.0, 57.5, 51.9, 44.6, 34.3, 26.9, 26.4 8, 155.4, 152.6, 149.8, 143.5, 142.1, 137.0, 123.0, 120.0, 118.8, 116.1, 113.4, 112.5, 105.4, 82.0, 79.9, 78.2, 60.9, 52.3, 35.3, 26.7, 26.3, 14 EtOH (50%, 15 ml), Et 3 N (0.60 ml) was added and the reaction were stirred for 36 h.
5-(6-Amino-9H-purin-9-yl)-5,6-dideoxy-1,2-O-isopropylidene-3-O-benzyl-α-D-glucoheptofuranose (27
Solvent evaporated under reduced pressure with an azeotrop of EtOH and C 6 H 5 CH 3 to give a residual mass which was subjected to column chromatography over SiO 2 using CHCl 3 / MeOH (9:1) as eluent to give title compound (43) as white solid in 88% yield. 8, 156.5, 152.7, 149.7, 143.6, 141.6, 138.9, 122.5, 119.4, 116.8, 115.5, 112.9, 111.9, 105.3, 82.1, 79.6, 78.9, 51.5, 36.2, 27.1, 26.5 197.6, 156.9, 153.8, 149.6, 139.8, 139.4, 135.6, 130.1, 122.6, 119.9, 27.3 Briefly, two fold serial dilutions of compounds and chloroquine were prepared in 96 well plates and then 50 µL asynchronous cultures of infected erythrocytes with 0.8-1%
parasitaemia and 1% haematocrit was added to each well (100 µL-final volume). Eight wells were treated as positive control (without drug) and 4 wells as negative control (without parasite and drug). These plates were incubated in CO 2 incubator maintained at 37 °C for 72 h. Then 00 μ lyti buffer ontaining S R Green final on entration was added to ea h well and in ubated in C CO 2 incubator for 2 h.
Plates were read under fluorescence reader at Ex. 485 nm, Em. 535 nm. Fifty percent inhibitory concentration (IC 50 ) was determined by quantifying DNA in treated and control cultures of parasites in human erythrocytes according to the SYBR Green I (Invitrogen) fluorescence based method.
Cytotoxicity Assay
Cytoto i ity of ompounds was determined a ording to O' rien et. al. (2000) method with few modifications. 54 The monkey kidney cell line (VERO) was maintained in vitro in MEM medium (Sigma) supplied with 15% fetal bovine serum (FBS) and 5% CO 2 at 37 °C. An appropriate serial drug dilution was prepared in culture plates and the cells were exposed to the concentrations of particular compounds for three days, 10% resazurin, a cell viability marker, was added and read
